Abstract
This chapter starts by discussing the status of COVID-19 and ways to improve the situation. Then it presents a general plan (prepared by the World Health Organization) for controlling a pandemic. Next, four methods to prepare for future pandemics are introduced. One involves the use of sharks’ antibody-like proteins as effective therapeutics against coronaviruses. A second way is called the One Health plan that recognizes the interconnections and health interdependencies among humans, animals, and shared environments where we live and interact. Another one is the use of serological testing, checking blood serum to detect antibodies that are formed in response to an infection from a pathogen. Finally, metagenomic sequencing is described. This approach reads the genomic material in a sample and identifies the organisms present.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Nature Medicine Editorial. (2021). Preparing for the next pandemic. Nature Medicine, 27, 357. https://doi.org/10.1038/s41591-021-01291-z
Disparte, D. (2021). Preparing for the next pandemic: Early lessons from COVID-19. Brookings report. Retrieved from brookings.edu
Osterholm, M. T. (2005). Preparing for a pandemic. The New England Journal of Medicine, 352, 1839.
Johnson, N. P., & Mueller, J. (2002). Updating the accounts: Global mortality of the 1918-1920 Spanish influenza pandemic. Bulletin of the History of Medicine, 76, 105–115.
Stohr, K. (2005). Avian influenza and pandemics: Research needs and opportunities. The New England Journal of Medicine, 352, 405–407.
Sandman, P. M., & Lanard, J. (2005). Pandemic influenza risk communication: The teachable moment. Peter Sandman. Retrieved April 14, 2005, from http://www.psandman.com/col/pandemic.htm
Kobasa, D., Takada, A., Shinya, K., et al. (2004). Enhanced virulence of influenza A viruses with haemagglutinin of the 1918 pandemic virus. Nature, 431, 703–707.
Peiris, J. S., Yu, W. C., Leung, C. W., et al. (2004). Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet, 363, 617–619.
Iserson, K. V. (2020). The next pandemic: Prepare for “Disease X”. The Western Journal of Emergency Medicine, 21(4), 756–758. https://doi.org/10.5811/westjem.2020.5.48215
Heymann, D. L., & Rodier, G. (2004). SARS: Lessons from a new disease. In Learning from SARS: Preparing for the next disease outbreak (pp. 234–245). The National Academies Press. Retrieved May 8, 2020, from www.ncbi.nlm.nih.gov/books/NBK92462/pdf/Bookshelf_NBK92462.pdf
Alfani, G., & Murphy, T. E. (2017). Plague and lethal epidemics in the pre-industrial world. The Journal of Economic History, 77(1), 314–343.
WHO. (n.d.). Prioritizing diseases for research and development in emergency contexts. Author. Retrieved April 8, 2020, from www.who.int/activities/prioritizing-diseases-for-research-and-development-in-emergency-contexts
US Centers for Disease Control and Prevention. (n.d.). National pandemic influenza plans. CDC. Retrieved May 9, 2020, from www.cdc.gov/flu/pandemic-resources/planning-preparedness/national-strategy-planning.html
US Department of Health and Human Services. (2017). Pandemic influenza plan. CDC. Retrieved May 9, 2020, from www.cdc.gov/flu/pandemic-resources/pdf/pan-flu-report-2017v2.pdf
US Department of Homeland Security. (2019). National response framework (4th ed.). FEMA. Retrieved May 9, 2020, from www.fema.gov/media-library-data/1582825590194-2f000855d442fc3c9f18547d1468990d/NRF_FINALApproved_508_2011028v1040.pdf
Assistant Secretary for Preparedness and Response. National health security strategy and implementation plan: 2015–2018. Author. Retrieved May 9, 2018, from www.phe.gov/Preparedness/planning/authority/nhss/Documents/nhss-ip.pdf
Desmond-Hellmann, S. (2020). Preparing for the next pandemic. Wall Street Journal. Retrieved April 4, 2020, from www.wsj.com/articles/preparing-for-the-next-pandemic-11585936915?mod=itp_wsj&mod=&mod=djemITP_h
Kelland, K. (2016). The World Health Organization’s critical challenge: Healing itself. Reuters. Retrieved May 7, 2020, from www.reuters.com/investigates/special-report/health-who-future/
Kamradt-Scott, A. WHO’s to blame? The World Health Organization and the 2014 Ebola outbreak in West Africa. Third World Quarterly. Retrieved May 7, 2020, from www.tandfonline.com/doi/full/10.1080/01436597.2015.1112232
Centers for Disease Control and Prevention. (n.d.). II. Lessons learned. Supplement G: Communication and education. Public health guidance for community-level preparedness and response to Severe Acute Respiratory Syndrome (SARS). Version 2/3. Retrieved May 8, 2020, from https://www.cdc.gov/sars/guidance/g-education/lessons.html
Johnson, M. (2021). UW researcher finds an unusual possibility for treating people with COVID-19: Shark antibodies. Milwaukee Journal Sentinel. UW study finds hope against COVID in unlikely source: Shark antibodies. Retrieved from jsonline.com
Ubah, O. C., Lake, E. W., Gunaratne, G. S., et al. (2021). Mechanisms of SARS-CoV-2 neutralization by shark variable new antigen receptors elucidated through X-ray crystallography. Nature Communications, 12, 7325. https://doi.org/10.1038/s41467-021-27611-y
Yadav, P. D., et al. (2021). Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. Clinical Infectious Diseases, 74, 366. https://doi.org/10.1093/cid/ciab411
Greaney, A. J., et al. (2021). Comprehensive map** of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies. Cell Host & Microbe, 29, 463–476.e466.
Liu, Y., et al. (2021). Neutralizing activity of BNT162b2-elicited serum. The New England Journal of Medicine, 384, 1466–1468.
Wang, P., et al. (2021). Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Nature, 593, 130–135.
Couzin-Frankel, J. (2021). Relief and worry for immune-suppressed people. Science, 372, 443–444.
Boyarsky, B. J., et al. (2021). Immunogenicity of a single dose of SARS-CoV-2 messenger RNA vaccine in solid organ transplant recipients. JAMA, 325, 1784–1786.
Huang, Y., et al. (2020). Neutralizing antibodies against SARS-CoV-2: Current understanding, challenge, and perspective. Antibody Therapeutics, 3, 285–299.
Greenberg, A. S., et al. (1995). A new antigen receptor gene family that undergoes rearrangement and extensive somatic diversification in sharks. Nature, 374, 168–173.
Stanfield, R. L., Dooley, H., Flajnik, M. F., & Wilson, I. A. (2004). Crystal structure of a shark single-domain antibody V region in complex with lysozyme. Science, 305, 1770–1773.
Stanfield, R. L., Dooley, H., Verdino, P., Flajnik, M. F., & Wilson, I. A. (2007). Maturation of shark single-domain (IgNAR) antibodies: Evidence for induced-fit binding. Journal of Molecular Biology, 367, 358–372.
Stevelaycock21. (2020). File: Nurse shark turning.jpg. License: Creative Commons Attribution-Share Alike 4.0 International. File: Nurse shark turning.jpg - Wikimedia Commons.
Daily Excelsior. (2021). One health: A crucial approach to preventing and preparing for future pandemics - Jammu Kashmir Latest News. Tourism. Breaking News J&K. Daily Excelsior. Retrieved from dailyexcelsior.com
Katsnelson, A. (2020). Making the leap. Chemical & Engineering News, 27–33.
Greenwood, V. (2021). Trying to track new viruses before an outbreak. The New York Times, D4.
Kalantar, K. L., Carvalho, T., de Bourcy, C., Dimitrov, B., Dingle, G., Egger, R., Han, J., Holmes, O. B., Juan, Y. F., King, R., Kislyuk, A., Lin, M. F., Mariano, M., Morse, T., Reynoso, L. V., Cruz, D. R., Sheu, J., Tang, J., Wang, J., Zhang, M. A., DeRisi, J. L. (2020). IDseq-An open-source cloud-based pipeline and analysis service for metagenomic pathogen detection and monitoring. GigaScience, 9(10), giaa111. https://doi.org/10.1093/gigascience/giaa111
Zeeberg, A. (2021). A mission to piece together the next pandemic. The New York Times, D5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Barry, D.M., Kanematsu, H. (2022). Controlling COVID-19 and Preparing forFuture Pandemics. In: Barry, D., Kanematsu, H. (eds) Studies to Combat COVID-19 using Science and Engineering. Springer, Singapore. https://doi.org/10.1007/978-981-19-1356-3_11
Download citation
DOI: https://doi.org/10.1007/978-981-19-1356-3_11
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-19-1355-6
Online ISBN: 978-981-19-1356-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)